253 related articles for article (PubMed ID: 29314523)
1. Pneumocystis jirovecii pneumonia in patients with acute myeloid leukaemia.
Chang H; Kuo MC; Lin TL; Wu JH; Wang PN
Intern Med J; 2018 Jan; 48(1):81-83. PubMed ID: 29314523
[TBL] [Abstract][Full Text] [Related]
2. Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia.
Paterno G; Guarnera L; Palmieri R; Del Prete V; Bonanni F; Buzzatti E; Moretti F; Casciani P; Savi A; Di Cave D; Maurillo L; Buccisano F; Venditti A; Del Principe MI
Mycoses; 2022 Feb; 65(2):233-238. PubMed ID: 34883533
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
[TBL] [Abstract][Full Text] [Related]
4. Low incidence of Pneumocystis jirovecii pneumonia in an unprophylaxed liver transplant cohort.
Sarwar S; Carey B; Hegarty JE; McCormick PA
Transpl Infect Dis; 2013 Oct; 15(5):510-5. PubMed ID: 23930824
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis jirovecii pneumonia in African miners at autopsy.
Wong ML; Back P; Candy G; Nelson G; Murray J
Int J Tuberc Lung Dis; 2006 Jul; 10(7):756-60. PubMed ID: 16848337
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis jirovecii pneumonia [PJP]: An unrecognized concern in AML patients on Venetoclax.
Rainchwar S; Halder R; Singh R; Mehta P; Verma M; Agrawal N; Ahmed R; Bhurani D; Bansal N
Leuk Res; 2022 Oct; 121():106926. PubMed ID: 35994889
[TBL] [Abstract][Full Text] [Related]
7. Single-center outbreak of Pneumocystis jirovecii pneumonia in heart transplant recipients.
Veronese G; Ammirati E; Moioli MC; Baldan R; Orcese CA; De Rezende G; Veronese S; Masciocco G; Perna E; Travi G; Puoti M; Cipriani M; Tiberi S; Cirillo D; Frigerio M
Transpl Infect Dis; 2018 Jun; 20(3):e12880. PubMed ID: 29514393
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction-based diagnosis in patients receiving bendamustine.
Rice ML; Barreto JN; Thompson CA; Mara KC; Tosh PK; Limper AH
Cancer Med; 2021 Aug; 10(15):5120-5130. PubMed ID: 34155819
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, mortality and effectiveness of prophylaxis for Pneumocystis jiroveci pneumonia among rheumatic patients: a territory-wide study.
Chan SCW; Chung HY; Lau CS; Li PH
Ann Clin Microbiol Antimicrob; 2021 Nov; 20(1):78. PubMed ID: 34763703
[TBL] [Abstract][Full Text] [Related]
10. Healthcare-associated Pneumocystis jirovecii Pneumonia (PJP) Infection in HIV-negative Adults: a Multicenter Study.
Zalmanovich A; Ben-Ami R; Rahav G; Alon D; Moses A; Olshtain-Pops K; Weinberger M; Shitrit P; Katzir M; Gottesman BS; Chowers M
Isr Med Assoc J; 2021 May; 23(5):312-317. PubMed ID: 34024049
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis jiroveci pneumonia in patients receiving dasatinib treatment.
Chang H; Hung YS; Chou WC
Int J Infect Dis; 2014 Aug; 25():165-7. PubMed ID: 24932855
[TBL] [Abstract][Full Text] [Related]
12. A Multivariable Prediction Model for Pneumocystis jirovecii Pneumonia in Hematology Patients with Acute Respiratory Failure.
Azoulay E; Roux A; Vincent F; Kouatchet A; Argaud L; Rabbat A; Mayaux J; Perez P; Pène F; Nyunga M; Bruneel F; Klouche K; Mokart D; Darmon M; Chevret S; Lemiale V
Am J Respir Crit Care Med; 2018 Dec; 198(12):1519-1526. PubMed ID: 29995433
[TBL] [Abstract][Full Text] [Related]
13. Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: A case-control study.
Tadros S; Teichtahl AJ; Ciciriello S; Wicks IP
Semin Arthritis Rheum; 2017 Jun; 46(6):804-809. PubMed ID: 27814896
[TBL] [Abstract][Full Text] [Related]
14. Real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia.
Fillaux J; Berry A
Methods Mol Biol; 2013; 943():159-70. PubMed ID: 23104289
[TBL] [Abstract][Full Text] [Related]
15. Retrospective review of Pneumocystis jirovecii pneumonia over two decades.
Travis J; Hart E; Helm J; Duncan T; Vilar J
Int J STD AIDS; 2009 Mar; 20(3):200-1. PubMed ID: 19255271
[TBL] [Abstract][Full Text] [Related]
16. Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands host or environmental factors?
Schoffelen AF; van Lelyveld SF; Barth RE; Gras L; de Wolf F; Netea MG; Hoepelman AI;
AIDS; 2013 Apr; 27(7):1179-84. PubMed ID: 23276810
[TBL] [Abstract][Full Text] [Related]
17. Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis.
Haeusler GM; Slavin MA; Seymour JF; Lingaratnam S; Teh BW; Tam CS; Thursky KA; Worth LJ
Eur J Haematol; 2013 Aug; 91(2):157-63. PubMed ID: 23668894
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnosis of Pneumocystis jirovecii in patients with malignancy: clinical significance of quantitative polymerase chain reaction.
Teh BW; Azzato FA; Lingaratnam SM; Thursky KA; Slavin MA; Worth LJ
Med Mycol; 2014 May; 52(4):427-32. PubMed ID: 24625674
[TBL] [Abstract][Full Text] [Related]
19. Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients.
Ricciardi A; Gentilotti E; Coppola L; Maffongelli G; Cerva C; Malagnino V; Mari A; Di Veroli A; Berrilli F; Apice F; Toschi N; Di Cave D; Parisi SG; Andreoni M; Sarmati L
PLoS One; 2017; 12(5):e0176881. PubMed ID: 28505159
[TBL] [Abstract][Full Text] [Related]
20. Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals.
Li MC; Lee NY; Lee CC; Lee HC; Chang CM; Ko WC
J Microbiol Immunol Infect; 2014 Feb; 47(1):42-7. PubMed ID: 23063081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
